A serological survey of monkeys was conducted to determine the prevalence of antibody to human herpesvirus 6 (HHV-6). Two-hundred and fifteen sera from 10 species of monkeys were examined by an immunofluorescent antibody (IF) assay. The antibody was found in monkeys from eight of the 10 species examined, but was not detected in silvered lutongs or cotton-top tamarins. The prevalence of antibody was highest in squirrel monkeys. Sera with high antibody titres were examined further by Western blot analysis and the neutralizing antibody test and the antibody levels were compared with that from a patient with exanthem subitum. On Western blotting, monkey and human sera that were antibody-positive to HHV-6 antigen gave similar reactions with antigen components of almost the same Mr. Furthermore, sera that were antibody-positive by the IF test were also positive by the neutralizing antibody test and their titres in the two tests were comparable. These results suggest the existence of HHV-6 or an HHV-6-related virus in monkeys.
INTRODUCTION
A novel human herpesvirus, now referred to as human herpesvirus 6 (HHV-6), was independently isolated by several groups from patients with lymphocytic disorders and also from normal adults Downing et al., 1987 ; Tedder et al., 1987; Lopez et al., 1988) . The virus was initially designated human B lymphotropic virus, because it was reported to replicate only in B lymphocytes , but recently it was reported that it mainly infects and replicates in lymphocytes of T cell lineage (Tedder et al., 1987; Lusso et al., 1988; Agut et al., 1988) .
HHV-6 is an enveloped virus, about 200 nm in diameter, with an electron-dense icosahedral core composed of 162 capsomeres containing a large, double-stranded DNA genome . Preliminary characterization of HHV-6 indicated that it was antigenically distinct from the other human herpesviruses, i.e. human cytomegalovirus (HCMV), herpes simplex virus types 1 and 2, variceUa-zoster virus and Epstein-Barr virus Lopez et al., 1988) . However, Efstathiou and colleagues (1988) found that the HHV-6 genome has sequence homology with that of HCMV. Most children have antibodies against HHV-6 by the time they are 2 years old (Briggs et al., 1988; Knowles & Gardner, 1988; Okuno et al., 1989) , but it was not known whether HHV-6 causes disease in humans. We recently reported that HHV-6 is a causative agent of exanthem subitum (Yamanishi et al., 1988) but there is no report on whether animals are infected with this virus. We report here the prevalence of antibodies to HHV-6 antigen in various kinds of Old and New World monkeys.
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Sera. Sera were obtained from monkeys (cynomolgus monkeys, African green monkeys, chimpanzees, cottontop tamarins and common squirrel monkeys) maintained at animal facilities of four research institutes in Japan and monkeys (orang-utan, pig-tail monkey, siamang and silvered lutong) kept in a zoo in Indonesia. Sera were also obtained from a group of cynomolgus monkeys captured in a forest in Indonesia and from Japanese monkeys in two colonies in different parts of Japan.
Preparation of virus and antigen. Cord blood lymphocytes were infected with HHV-6 (Hashimoto strain), which was isolated in our laboratory from a patient with exanthem subitum (Yamanishi et al., 1988) and were cultured in RPMI-1640 medium supplemented with recombinant interleukin-2 (a gift from Takeda Chemical Industries), phytohaemagglutinin (Honen Oil Co.) and 10 ~ foetal calf serum (FCS) as described previously (Yamanishi et al., 1988) . When c.p.e were observed, approximately 1 to 2 weeks after infection, the cells were collected by centifugation and infected cells were disrupted by sonication. The supernatant obtained by centrifugation at 3000 r.p.m, at 4 °C was inoculated onto HPB-ALL cells, which had been derived from an acute lymphatic leukaemia cell line (ALL) and cultured in RPMI-1640 medium supplemented with 10 ~ FCS. When some cells showed c.p.e. with characteristic balloon-like syncytia the cells were mounted on 24-spot glass slides and fixed in acetone at -20 °C for 10 min. Uninfected cells on 24-spot glass slides were also prepared in the same way. In the indirect immunofluorescence (IF) test, approximately 30 to 50 ~ of the infected cells stained with antibody-positive human serum, whereas uninfected cells were not stained. Therefore, these HHV-6-infected HPB-ALL cells were used as standard cells for titration of serum antibody.
Serum sampling and antibody determination by the IF test. Serially diluted sera were mounted on spotted slides and incubated for 1 h at 37 °C and the slides were then washed twice with phosphate-buffered saline (PBS). Fluorescein isothiocyanate (FITC) conjugates of antibody to the primate species were not available, but commercial FITC-conjugated antibody to human IgG was successfully used in the indirect IF antibody test, as described elsewhere (Hayami et al., 1984) . The slides were then treated with FITC-conjugated goat anti-human IgG (Cappel) and incubated for another 30 rain at 37 °C. After washing with PBS, the slides were mounted in glycerin buffer and observed with a fluorescence microscope. Titres of antibodies were expressed as the highest serum dilution yielding detectable immunofluorescence. Serum that gave positive staining when diluted 1 : 20 with PBS was regarded as anti-HHV-6 antibody-positive, because sera at dilutions lower than 1 : 20 sometimes gave non-specific staining.
Some human and monkey sera were treated with Protein G-Sepharose (Pharmacia) to absorb IgG in sera. An aliquot of serum was mixed with Protein G-Sepharose and incubated overnight at 4 °C with occasional agitation. The mixture was centrifuged, the supernatant collected and the treated samples were titrated by the IF test, as described above.
Western blot analysis. Cord blood lymphocytes were infected with HHV-6 at an m.o.i, of 0.1 TCIDso/cell and cultured as described above. Once c.p.e, were observed in cultured cells they were washed three times with PBS and solubilized in sample buffer (0.125 ~-Tris-HCl pH 7-0, l% SDS, 8.5~ sucrose, 5~ 2-mercaptoethanol, 0-001 ~ phenol red); the lysate was then boiled for 3 min. Electrophoresis was carried out on 10 ~ polyacrylamide slab gels of 1.0 mm thickness. The internal Mr standards used were ct-lactalbumin (14K), soybean trypsin inhibitor (20K), carbonicanhydrase (30K), ovalbumin (43K), albumin (67K), phosphorylase b (94K), lactate dehydrogenase (140K), catalase (232K), ferritin (440K) and thyroglobulin (669K), all purchased from Pharmacia.
After electrophoretic separation, proteins were transferred electrophoretically to Durapore sheets (Millipore). The sheets were washed with skimmed milk and incubated with 1 : 50 dilutions of serum samples. A biotinylated anti-human IgG F(ab')2 fragment (Amersham) served as a second antibody. Binding of antibodies was detected by subsequent addition of streptavidin-horseradish peroxidase complex and staining with a Konica immunostaining HRP kit, IS-50B.
Neutralizing antibody (NT) test. The titre of HHV-6 neutralizing antibodies in sera was assessed by an antigenpositive cell reduction assay in 96-well microplates using MT-4 cells, which were derived from an adult T cell leukaemia (Miyoshi et al., 1982) . Serial dilutions of serum in 96 wells were incubated with a known quantity of HHV-6 (Hashimoto strain; 2000 TCIDso ) for 1 h at 37 °C and then MT-4 cells (approximately 105 cells/well) were added to the wells. Cultures were incubated for 3 days at 37 °C in a CO2 incubator. The cells in each well were then mounted on glass 24-spot slides, dried completely and fixed in cold acetone for 20 min at -20 °C. Monoclonal antibodies against HHV-6 (unpublished results) were added and the slides were then incubated at 37 °C for 1 h and washed three times with PBS. FITC-labelled goat anti-mouse IgG F(ab')2 fragment (Cappel) was added and the slides were incubated for another 30 rain at 37 °C, washed three times with PBS and observed under a fluorescence microscope. The number of antigen-positive cells in each spot was counted and a serum sample was considered positive when it reduced the number of cells showing viral antigen by at least 80~ when compared with the control number.
RESULTS

Prevalence of antibody to HHV-6 in various monkeys
A total of 215 sera from monkeys of 10 different species (cynomolgus, African green, chimpanzee, orang-utan, pig-tail, siamang, silvered lutong, Japanese tamarin and squirrel monkeys) were examined for antibody to HHV-6. Antibody was found in monkeys from eight of the 10 species, although the positive rate varied from 100~ to 10~, depending on where the monkeys were living. The antibody-positive rates in chimpanzees, orang-utans, siamangs and squirrel monkeys were 90 ~, 75 ~, 100 ~ and 70 ~ respectively. No antibody was found in sera of tamarins or silvered lutongs (Fig. 1, Table 1 ). Sera from cynomolgus, African green monkeys and chimpanzees from different areas showed a range of values when examined for antibody to H HV-6; the antibody-positive rates varied from 26~ to 40~o in cynomolgus monkeys, from 40 to 100~ in African green monkeys and from 75 ~ to 90~ in chimpanzees from various localities.
Western blot analysis
First, the antigen lanes were treated with sera obtained from a patient with exanthem subitum at day 3 (acute phase) and day 30 (convalescent phase) of the disease. No band was seen in the lane treated with serum obtained in the acute phase of exanthem subitum, or in lanes of noninfected antigen reacted with a convalescent serum, or with sera from three of the monkeys (Fig.  2, lanes 3 to 8) . However, one major band with an M r of approximately 94K and a few other minor bands were observed on treatment with serum obtained in the convalescent phase (Fig. 2,  lane 9) . Next, three serum samples from monkeys were used for this reaction. The 94K band was deeply stained with antibody-positive serum with a titre of 1 : 320 by the IF test and other minor bands were also observed with this serum. This band was also stained with two other sera with antibody titres of 1:40 and 1:20 (Fig. 2, lanes 11 and 12) . Areas A, B and D, Medical institutions in Japan; area E, a monkey centre in Africa; area F, a zoo in Indonesia. Monkeys in group C were captured in the forest and bled in Indonesia, groups G and H were wild monkeys in Japan.
Neutralizing antibody test
The titres of two pairs of sera (four samples) from patients with e x a n t h e m subitum and eight sera from monkeys in the I F a n d N T tests were compared (Table 2 ). The antibody titres of the sera of the two patients were less than 1 : 20 by the I F and N T tests during the acute phase of disease and increased to 1:320 to 1:640 by the I F test and 1 : 160 to 1 "320 by the N T test during t Antibody titres in sera before and after treatment with Protein G-Sepharose.
the convalescent phase. The antibody titres in these two tests differed twofold. When sera from monkeys were tested by the two methods, the antibody was found in five sera and the extent of neutralization of HHV-6 by these sera was similar to that by the human convalescent sera. Furthermore, the titres estimated by the two methods were comparable. Sera of patients and monkeys were treated with Protein G-Sepharose and their titres were estimated by the IF test. No antibody (less than 1 : 20) was detected in sera after this treatment, which suggested that the cross-reactivity was mediated by an antibody-antigen reaction. Salahuddin and associates (1986) did not find any antibody reacting to HHV-6 in monkeys. However, the present results demonstrated that an HHV-6-retated virus is widely distributed in monkeys. The prevalence of its antibody varied greatly, from 100 ~ in African green monkeys to 0~ in silvered lutongs and cotton-top tamarins. Since it was not possible to use species-specific antibodies in the IF test, it is possible that the negative results for tamarins and silvered lutongs were due to their immunoglobulins not reacting with anti-human IgG. However we could not detect any neutralizing antibody in sera of tamarins (data not shown),
DISCUSSION
It is important to determine whether the antibodies detected in monkeys in this study are directed to HHV-6 or to an HHV-6-related virus that may exist in monkeys and show antigenic cross-reactivity with HHV-6. There is reported to be some cross-reactivity between human herpesviruses and those of monkeys (Hull et al., 1972) . To determine whether HHV-6 exists in monkeys, we first used Western blot analysis with sera from a patient in the convalescent phase of exanthem subitum and sera from monkeys and compared the patterns on SDS-PAGE. As shown in Fig. 2 , the patterns were very similar and a major band with an Mr of 94K was detected with all the sera and some minor bands of similar Mr were detected with sera containing high antibody titres. The NT test was then used to examine the prevalence of antibody and the titres of antibody were compared with those determined by the IF test. Paired sera from two patients with exanthem subitum (taken in the acute and convalescent phases) were also examined by the two methods. The human and monkey sera gave similar ratios of antibody titres determined by the two methods. These findings suggest that HHV-6 also infects monkeys, but for confirmation of this the virus must be isolated from monkeys and compared with the human virus at the polypeptide and DNA levels.
It is interesting to consider the route of infection of this virus. The prevalence of antibody in groups of cynomolgus monkeys which were kept in an institute (area A) and those captured in Indonesia (group C) was not very different. On the other hand, no antibody was found in cottontop tamarins, whereas all the squirrel monkeys examined had the antibody, although the animals of these two species were kept in the same place in Japan. Furthermore, the antibodypositive rates in orang-utans and siamangs were relatively high (75~ and 71 ~, respectively), and those in pig-tailed monkeys and silvered lutongs were low (17 ~ and 0 ~, respectively), even though these monkeys were all kept in the same zoo in Indonesia. The antibody-positive rate to HHV-6 in humans is approximately 80~ and does not differ greatly with age . Moreover the prevalence of antibody in primates (orang-utan and chimpanzees) is similar to that in humans. These data suggest that susceptibility to HHV-6 varies between different species of monkeys. The route of transmission of this virus in humans is not known, but it can be supposed that there are two possible routes of transmission in monkeys, i.e. from mother to child at an early age and from humans to monkeys.
With most viruses it is difficult to develop an animal model of virus infection, but in the case of HHV-6 it might be possible to use sensitive species of monkeys to provide information on the route of infection and this may also be helpful in developing drugs or vaccines for prevention of viral infection.
